Responses
Oncolytic and local immunotherapy
Original research
Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.